ALFA Finder| Revenue growth | FY26: ₹137.4cr; FY27 Target: 60-70% growth. |
|---|---|
| Margins | Targeting 30% EBITDA margins; female condoms offer 30-40% higher margins. |
| Demand visibility | High due to institutional procurement and rising sexual health awareness. |
| Management confidence | Strong; cite domestic leadership and export expansion. |
Growth
FY26 revenue reached ₹13,741.57 lakhs with EBITDA of ₹5,150.85 lakhs (37.5% margin).
Outlook
Guiding 60-70% revenue growth by FY27 with 30% EBITDA margins; targeting 25% export contribution.
Risks
Fluctuating latex raw material prices and dependence on government/institutional procurement cycles.
Earnings Call filed with NSE, NSE: ANONDITA. Summary written with AI assistance from the document.
Anondita Medicare Ltd: key numbers
- Share price
- ₹1,056.60
- Market cap
- ₹2,012 Cr
- Revenue (annual)
- ₹137.4 Cr
- Net profit (annual)
- ₹33.45 Cr
- P/E (TTM)
- 60.2×Sector 41.3×
- Promoter holding
- 59.26%
- FII holding
- 2.58%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anondita Medicare Ltd
All →Anondita Medicare Bags New Order from Central Medical Services Society, Ministry of Health and Family...
Anondita Medicare received a purchase order from the Central Medical Services Society (Ministry of Health, Govt. of India) to supply 4,20,09,460 condoms. Delivery is due in two tranches within 180 days, with no rupee value disclosed.
- From
- Central Medical Services Society, Ministry of Health and Family Welfare (Government of India)
- Execution
- Tranche I: 50% within 90 days of PO; Tranche II: balance 50% within 91-180 days of PO
Anondita Medicare Business Update
Anondita Medicare appointed six distribution partners across Nepal, Bhutan, and Bangladesh for COBRA condoms and healthcare products. Sales have commenced in Nepal through one partner.
Anondita Medicare Other Announcement
Anondita Medicare Limited has submitted a certificate stating that the compliance report on corporate governance under Regulation 27(2) is not applicable to the company.
Anondita Medicare Annual General Meeting
Anondita Medicare Limited reported the proceedings of its 3rd Annual General Meeting held on September 29, 2026, where several ordinary and special businesses were discussed.
Anondita Medicare Capital Structure Change
Anondita Medicare Limited has reinstated its previous rights issue corrigendum. The issue size is now confirmed at 9,58,166 equity shares, aggregating to ₹91.03 Crore.
- Value
- ₹91.03 Cr
Anondita Medicare Capital Structure Change
Anondita Medicare Limited issued a corrigendum to its Rights Issue, revising the total issue size to ₹91.03 Crore and adjusting the allocation for general corporate purposes.
- Value
- ₹91.03 Cr